Hunting for Biomarkers in Paraffin Wax

Tony Hagen @oncobiz
Published: Tuesday, Jun 13, 2017
Barrett Rollins, MD, PhD

Barrett Rollins, MD, PhD

Large panel gene assays come with so much information that oncologists may have difficulty putting all of the data to practical use, Barrett Rollins, MD, PhD, chief scientific officer at Dana-Farber Cancer Institute, said. “I think the practitioner understands very well that for certain diseases, there are genetic biomarkers that are very important, and he or she understands how to use that, but when confronted with a report on 400 different mutations at different locations in the genome, it’s not clear to me that people know how to make sense of that,” Rollins said.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x